For example, given the increasing number of influenza cases in cities like Florianópolis, the ND+ portal seeks to answer one question: Ultimately, will it work against the disease? The second one is infectious disease doctor Amaury Mielle, not quite.
Finally, does it work against the flu? – Photo: Unsplash/Divulgação/NDMiller said there’s no scientific evidence or detailed studies that show any drug doesn’t work against viruses like the flu.
“We are dealing with an infectious disease caused by a virus, not the influenza virus. When we talk about drugs, we are talking about things that we can directly fight against the virus, inhibiting its replication,” the doctor explained.
Secondly, Mielle, medically, there is currently no effective drug that can eliminate the flu virus, let alone you.
“In fact, using infusions can help rehydrate patients and provide comfort. Many times, just drinking tea for a few minutes can create a placebo effect, and belief in the effectiveness of the treatment contributes to the patient’s health,” he concluded.
Are everyone in the city sick?
If you walk the streets of Florianópolis in late October and early November this year, you will usually notice different people breathing in and showing flu symptoms.To understand the ending, everyone in town is sick, or ND+Portal I’m looking for some data from cities.
Flu cases in Florianópolis cannot be uploaded – Photo: Freepik/Divulgação/NDAccording to Fiocruz (Fundação Oswaldo Cruz), there has been an increase in SARS (Severe Acute Respiratory Syndrome) cases in the city, as well as in six other Brazilian capitals.
The second Infoflu Bulletin compiled by Fiocruz shows that the prevalence of influenza A among cases testing positive for respiratory viruses during the past four epidemiological weeks was 1.7%; influenza B was 0.4%; Respiratory syncytial virus (RSV) is 8.3%; e Sars-CoV-2 (Covid-19) is 58.4%.
Even among deaths, the proportion of the same virus present in those positive for influenza A was 1.1%; for influenza B, 0%; for influenza, 0.5%; and for Sars-CoV-2 (Covid-19), 81.4%.